Hematology NewsMCL treatment choices depend partly on ageOctober 10, 2018Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsPrognostic factors guide mantle cell treatment decisionsSeptember 28, 2018Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsOutpatient lenalidomide/rituximab yields long-term MCL remissionSeptember 25, 2018Mantle Cell LymphomaLymphoma & Plasma Cell DisordersAggressive LymphomasB Cell Lymphoma
Hematology NewsTP53 mutation plus complex karyotype equals poor prognosisSeptember 10, 2018Mantle Cell LymphomaLymphoma & Plasma Cell DisordersAggressive LymphomasB Cell Lymphoma
Hematology NewsAdverse events outweigh promise of SGN-CD70A against NHLAugust 30, 2018Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsNew BTK inhibitor under review in ChinaAugust 29, 2018Mantle Cell LymphomaAggressive LymphomasFollicular LymphomaB Cell Lymphoma
Hematology NewsMeta-analysis supports rituximab maintenance in MCLAugust 16, 2018Mantle Cell LymphomaAggressive LymphomasB Cell Lymphoma
Hematology NewsPET/CT accurately predicts MCL stageAugust 2, 2018Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersB Cell Lymphoma
Oncology PracticeLate mortality risk after childhood BMT is substantial, persistentJuly 28, 2018Lymphoma & Plasma Cell DisordersHodgkin LymphomaIndolent LymphomaMantle Cell Lymphoma
Hematology NewsNew guideline for managing MCLJuly 13, 2018Mantle Cell LymphomaLymphoma & Plasma Cell DisordersAggressive LymphomasB Cell Lymphoma
Hematology NewsBortezomib plus vorinostat shows modest response in MCLJune 29, 2018Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsBritish good practice paper offers MCL diagnosis pearlsJune 15, 2018Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell Disorders
Hematology NewsOvercoming TP53 mutation proves difficult in MCLJune 1, 2018Mantle Cell LymphomaLymphoma & Plasma Cell DisordersAggressive Lymphomas
Hematology NewsAdding bortezomib does not improve MCL outcomesMay 16, 2018Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell Disorders
